Skip to content
Search

Latest Stories

Almost all provisionally registered pharmacists have completed their risk assessment: GPhC

Almost all of the provisionally-registered pharmacists have completed their risk assessment by their respective employers, a new survey has shown.

The latest study by the General Pharmaceutical Council (GPhC) has revealed 90 per cent of provisionally registered pharmacists reported that their employers had completed their Covid-19 risk assessment.


Three per cent of the respondents informed that they hadn’t undergone any risk assessment, whereas eight per cent of them didn’t know about the assessment.

The research found 86 per cent of respondents were employed as pharmacists with the top two settings being community pharmacy (56 per cent) and hospital/secondary care (40 per cent).

Around 98 per cent of the total respondents had access to clinical advice and guidance if they needed it. Two per cent had concerns about their risk assessments and remaining respondents concerned about their access to clinical advice and guidance.

In some of the cases the survey has identified issues with risk assessments and access to clinical support. Commenting on such cases GPhC said: “We will contact employers to seek assurance that they have made steps to rectify these. Our inspectors will follow up where necessary with registered pharmacies.”

GPhC chief executive Duncan Rudkin said: “Employers of provisionally-registered pharmacists have an obligation to conduct individual risk assessments and meet requirements to protect patient safety and support provisionally-registered pharmacists.

“I want to thank all those who responded to the survey. These results indicate that the vast majority of employers are meeting our requirements and that provisionally-registered pharmacists are receiving the appropriate clinical advice and risk assessments.  We will be following up on the small number of cases where all of the requirements may not have been met.”

Provisionally-registered pharmacists who registered in August have been asked to complete a survey to help the GPhC to check that their employers were meeting requirements, including conducting a risk assessment.

Provisionally-registered pharmacists were also asked about the pharmacy setting they trained and work in, whether they had a named senior pharmacist and they had access to clinical advice and guidance if they needed it.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less